Serum NfL (sNfL) shows promise as a blood biomarker for monitoring neurodegenerative and neuroinflammatory diseases like Alzheimer’s disease and multiple sclerosis, and possible also for cerebral small vessel disease (cSVD)2,3. This evidence concerns the gene NEFL and cerebral small vessel disease.